Propylhexedrine

CHEMBL2105275 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
155.3 g/mol
LogP
3.5
Phase
4

Propylhexedrine is a sympathomimetic amine and alpha-adrenergic agonist structurally related to methamphetamine that acts as a potent vasoconstrictor of nasal mucosa blood vessels, reducing congestion and improving airflow through the nasal passages. It is available as an over-the-counter nasal decongestant inhaler, though it has abuse potential due to its CNS stimulant properties.

分子量

155.2800 g/mol

LogP

3.50

TPSA

12.00 Ų

Lipinski 五规则

符合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNC(C)CC1CCCCC1

InChI

InChI=1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3

Molecular Formula

C10H21N

HBD / HBA

1 / 1

可旋转键数

3

重原子数

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Propylhexedrine is a sympathomimetic amine and alpha-adrenergic agonist structurally related to methamphetamine that acts as a potent vasoconstrictor of nasal mucosa blood vessels, reducing congestion and improving airflow through the nasal passages. It is available as an over-the-counter nasal decongestant inhaler, though it has abuse potential due to its CNS stimulant properties.

Yes, Propylhexedrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105275. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 7558. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.